Dr McCormack has more than 20 years experience in medical technologies, from fundamental research to product development. He was previously a partner of Global Life Science Ventures (GLSV) and led their investment in IMI.
Prior to GLSV, he co-founded NeuroSystec for the development of therapeutics to treat neurological diseases and AlleCure which was merged with two other biotechnology companies and taken public as MannKind.
Vin Bucci, chairman of IMI, said: “We are very pleased to have Stephen leading IMI. His experience and familiarity with the field will be crucial to the success of the company.”